Erratum: Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders (Neuroscience and Biobehavioral Reviews DOI: S0149-7634(04)00082-X10.1016/j.neubiorev.2004.08.004);Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders

Neuroscience and Biobehavioral Reviews

Volumn 28, Issue 6, 2004, Pages 547-563

  Hesse, Swen ^a   Barthel, Henryk ^a   Schwarz, Johannes ^a   Sabri, Osama ^a   Müller, Ulrich ^b  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

PET; Serotonin transporter; SPECT

Indexed keywords

1,2,3,5,6,10B HEXAHYDRO 6 (4 METHYLTHIOPHENYL)PYRROLO[2,1 A]ISOQUINOLINE; CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; IODINE 123; PAROXETINE; RADIOLIGAND; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TRACER;

ANXIETY DISORDER; BRAIN INJURY; DEPRESSION; DISEASE SEVERITY; DRUG EFFECT; EATING DISORDER; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPOTHALAMUS; IMAGING; IN VIVO STUDY; ISOTOPE LABELING; MENTAL DISEASE; NEUROLOGIC DISEASE; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGICAL CRYING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC NERVE CELL; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE; THALAMUS; WILSON DISEASE;

EID: 7444220628     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2005.01.003     Document Type: Erratum

References (139)

1. 123I]ADAM and SPECT J Nucl Med 42 2001 1556 1565
2. H. Allain, D. Bentué-Ferrer, O. Tribut, M. Mérienne, and S. Belliard Drug therapy of frontotemporal dementia Hum Psychopharmacol Clin Exp 18 2003 251 255
3. B. Andree, A. Hedman, S.O. Thorberg, D. Nilsson, C. Halldin, and L. Farde Positron emission tomographic analysis of dose-dependent NAD-299 binding to 5-hydroxytryptamine-1A receptors in the human brain Psychopharmacology (Berl) 167 2003 37 45
4. V. Arango, Y.Y. Huang, M.D. Underwood, and J.J. Mann Genetics of the serotonergic system in suicidal behavior J Psychiatr Res 37 2003 375 386
5. K. Audenaert, K. Van Laere, F. Dumont, M. Vervaet, I. Goethals, and G. Slegers Decreased 5-HT2a receptor binding in patients with anorexia nervosa J Nucl Med 44 2003 166 169
6. 123I-β-CIT SPECT for imaging serotonin transporters in Parkinson's disease J Nucl Med 45 2004 923 924
7. C. Bell, J. Abrams, and D. Nutt Tryptophan depletion and its implications for psychiatry Br J Psychiatry 178 2001 399 405
8. 123I] CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy Nuklearmedizin 42 2003 31 38
9. 11C]WAY-100665 Biol Psychiatry 54 2003 890 895
10. L. Booij, A.J. Van der Does, and W.J. Riedel Monoamine depletion in psychiatric and healthy populations: review Mol Psychiatry 8 2003 951 973
11. A.L. Brody, M.W. Barsom, R.G. Bota, and S. Saxena Prefrontal-subcortical and limbic circuit mediation of depressive disorder Semin Clin Neuropsychiatry 6 2001 102 112
12. 123I]β-CIT. Binding kinetics in the human brain J Neural Transm Gen Sect 94 1993 137 146
13. 18F] fluoromethyl)-(+)-McN5652 Neuropsychopharmacology 28 2003 2410 2419
14. R. Buchert, R. Thomasius, B. Nebeling, K. Petersen, J. Obrocki, and L. Jenicke Long-term effects of 'ecstasy' use on serotonin transporters of the brain investigated by PET J Nucl Med 44 2003 375 384
15. A.J. Carson, B. Ringbauer, L. MacKenzie, C. Warlow, and M. Sharpe Neurological disease, emotional disorder, and disability: they are related: a study of 300 consecutive new referrals to a neurology outpatient department J Neurol Neurosurg Psychiatry 75 2000 242 246
16. 1A receptor antagonist, WAY-100665 Nucl Med Biol 27 2000 493 497
17. A. Caspi, K. Sugden, T.E. Moffitt, A. Taylor, I.W. Craig, H. Harrington, and J. McClay Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene Science 301 2003 386 389
18. S. Chalon, J. Tarkiainen, L. Garreau, H. Hall, P. Emond, and J. Vercouillie Pharmacological characterization of N,N-dimethyl-2-(2-amino-4- methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity J Pharmacol Exp Ther 304 2003 81 87
19. 1A receptors by clozapine in the primate brain: a PET study Psychopharmacology (Berl) 166 2003 234 240
20. Z. Cselenyi, J. Lundberg, C. Halldin, L. Farde, and B. Gulyas Joint explorative analysis of neuroreceptor subsystems in the human brain: application to receptor-transporter correlation using PET data Neurochem Int 45 2004 773 781
21. M. Dahlström, A. Ahonen, H. Ebeling, P. Torniainen, J. Heikkila, and I. Moilanen Elevated hypothalamic/midbrain serotonin (monoamine) transporter availability in depressive drug-naive children and adolescents Mol Psychiatry 5 2000 514 525
22. M.M. De Win, L. Reneman, J.B. Reitsma, G.J. Den Heeten, J. Booij, and W. Van Den Brink Mood disorders and serotonin transporter density in ecstasy users-the influence of long-term abstention, dose, and gender Psychopharmacology (Berl) 173 2004 376 382
23. W.C. Drevets, E. Frank, J.C. Price, D.J. Kupfer, D. Holt, and P.J. Greer PET imaging of serotonin 1A receptor binding in depression Biol Psychiatry 46 1999 1375 1387
24. B. Eggers, W. Hermann, H. Barthel, O. Sabri, A. Wagner, and S. Hesse The degree of depression in Hamilton rating scale is correlated with the density of presynaptic serotonin transporters in 23 patients with Wilson's disease J Neurol 250 2003 576 580
25. J.R. Fann Psychiatric effects of neuropharmacological agents Semin Clin Neuropsychiatry 7 2002 206 212
26. W.G. Frankle, and M. Laruelle Neuroreceptor imaging in psychiatric disorders Ann Nucl Med 16 2002 437 446
27. 123I]β-CIT binding in the striatum with clomipramine: is there a serotonin-dopamine interaction? Eur J Nucl Med 24 1997 403 408
28. P.W. Gold, and G.P. Chrousos Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states Mol Psychiatry 7 2002 254 275
29. J.A. Gingrich Mutational analysis of the serotonergic system: recent findings using knockout mice Curr Drug Target CNS Neurol Disord 1 2002 449 465
30. 11C]-DASB binding to the human serotonin transporter: modeling strategies J Cereb Blood Flow Metab 21 2001 1342 1353
31. 1A receptor ligand [carbonyl-11C]WAY-100665 for PET Neuroimage 8 1997 426 440
32. 123I]β-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients Mov Disord 16 2001 124 130
33. 11C]DADAM in humans Eur J Nucl Med 30 suppl 2 2003 S164
34. R. Hargreaves Imaging substance P receptors (NK1) in the living human brain using positron emission tomography J Clin Psychiatry 66 2002 18 24
35. A.R. Hariri, V.S. Mattay, A. Tessitore, B. Kolachana, F. Fera, and D. Goldman Serotonin transporter genetic variation and the response of the human amygdala Science 297 2002 400 403
36. A.R. Hariri, and D.R. Weinberger Functional neuroimaging of genetic variation in serotonergic neurotransmission Genes Brain Behav 2 2003 341 349
37. D. Healy The antidepressant era 1997 Harvard University Press Cambridge
38. A. Heinz, D.W. Jones, G. Bissette, D. Hommer, P. Ragan, and M. Knable Relationship between cortisol and serotonin metabolites and transporters in alcoholism [correction of alcolholism] Pharmacopsychiatry 35 2002 131 134
39. A. Heinz, D.W. Jones, C. Mazzanti, D. Goldman, P. Ragan, D. Hommer, and M. Linnoila A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity Biol Psychiatry 47 2000 643 649
40. A. Heinz, M.B. Knable, S.S. Wolf, D.W. Jones, J.G. Gorey, T.M. Hyde, and D.R. Weinberger Tourette's syndrome: [I-123]β-CIT SPECT correlates of vocal tic severity Neurology 51 1997 1069 1074
41. A. Heinz, P. Ragan, D.W. Jones, D. Hommer, W. Williams, and M.B. Knable Reduced central serotonin transporters in alcoholism Am J Psychiatry 155 1998 1544 1549
42. S. Hesse, H. Barthel, W. Hermann, T. Murai, R. Kluge, A. Wagner, and O. Sabri Regional serotonin transporter availability and depression are correlated in Wilson's disease J Neural Transm 110 2003 923 933
43. S. Hesse, H. Barthel, T. Murai, U. Müller, D. Müller, A. Seese, R. Kluge, and O. Sabri Is correction for age necessary in neuroimaging studies of the central serotonin transporter? Eur J Nucl Med Mol Imaging 30 2003 427 430
44. J. Hiltunen, K.K. Akerman, J.T. Kuikka, K.A. Bergstrom, C. Halldin, and T. Nikula Iodine-123 labeled nor-β-CIT as a potential tracer for serotonin transporter imaging in the human brain with single-photon emission tomography Eur J Nucl Med 25 1997 19 23
45. 11C]DASB Eur J Nucl Med 27 2000 1719 1722
46. 11C]AFM) Nucl Med Biol 31 2004 543 556
47. 11C]AFM J Cereb Blood Flow Metab 22 2002 1377 1397
48. 11C](+)McN5652 Biol Psychiatry 51 2002 715 722
49. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain J Cereb Blood Flow Metab 23 2003 1096 1112
50. L.K. Jacobsen, J.K. Staley, R.T. Malison, S.S. Zoghbi, J.P. Seibyl, and T.R. Kosten Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients Am J Psychiatry 157 2000 1134 1140
51. L.K. Jacobsen, J.K. Staley, S.S. Zoghbi, J.P. Seibyl, T.R. Kosten, and R.B. Innis Prediction of dopamine transporter binding availability by genotype: a preliminary report Am J Psychiatry 157 2000 1700 1703
52. S. Jovkar, K. Wienhard, H.H. Coenen, G. Pawlik, and W.D. Heiss Quantification of baboon cortical S2 serotonin receptors in vivo with 3-N-(2(-F18)fluoroethylspiperone and positron emission tomography Eur J Nucl Med 18 1991 158 166
53. V. Kaasinen, and R.O. Rinne Functional imaging studies of dopamine system and cognition in normal aging and Parkinson's disease Neurosci Biobehav Rev 26 2002 785 793
54. A.M. Kanner, and J.J. Barry The impact of mood disorders in neurological diseases: should neurologists be concerned? Epilepsy Behav 4 2003 3 13
55. S. Kasper, J. Tauscher, M. Willeit, M. Stamenkovic, A. Neumeister, and B. Kufferle Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder-implications for psychopharmacology World J Biol Psychiatry 3 2002 133 146
56. W.J. Katon, E. Lin, J. Russo, and J. Unutzer Increased medical costs of a population-based sample of depressed elderly patients Arch Gen Psychiatry 60 2003 897 903
57. 123I]ADAM in healthy human subjects: preliminary results Eur J Nucl Med Mol Imaging 30 2003 132 136
58. 11C McN 5652 Psychopharmacology (Berl) 164 2002 341 348
59. L. Kerenyi, G.A. Ricaurte, D.J. Schretlen, U. McCann, J. Varga, and W.B. Mathews Positron emission tomography of striatal serotonin transporters in Parkinson disease Arch Neurol 60 2003 1223 1229
60. 123I-β-CIT SPECT J Nucl Med 44 2003 870 876
61. S.E. Kim, W.Y. Lee, Y.S. Choe, and J.H. Kim SPECT measurement of iodine-123-β-CIT binding to dopamine and serotonin transporters in Parkinson's disease: correlation with symptom severity Neurol Res 21 1999 255 261
62. 123I]ADAM and SPECT in healthy human subjects: preliminary data on tracer kinetics Biol Psychiatry 55 2004 2125
63. V. Klimek, G. Roberson, C.A. Stockmeier, and G.A. Ordway Serotonin transporter and MAO-B levels in monoamine nuclei of the brainstem are normal in major depression J Psychiatr Res 37 2003 387 397
64. S. Klöppel, W. Pirker, T. Brücke, G.G. Kovacs, and G. Almer CITSPECT demonstrates reduced availability of serotonin transporters in patients with Fatal Familial Insomnia J Neural Transm 109 2002 1105 1110
65. A. Kugaya, N.M. Seneca, P.J. Snyder, S.A. Williams, R.T. Malison, and R.M. Baldwin Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration Neuropsychopharmacology 28 2003 413 420
66. J.T. Kuikka, L. Tammela, K.A. Bergström, L. Karhunen, M. Uusitupa, and J. Tiihonen Effects of ageing on serotonin transporters in healthy females Eur J Nucl Med 28 2001 911 913
67. J.T. Kuikka, L. Tammela, L. Karhunen, A. Rissanen, K.A. Bergstrom, and H. Naukkarinen Reduced serotonin transporter binding in binge eating women Psychopharmacology (Berl) 155 2001 310 314
68. J.T. Kuikka, J. Tiihonen, K.A. Bergström, J. Karhu, P. Hartikainen, and H. Viinamaki Imaging of serotonin and dopamine transporters in the living human brain Eur J Nucl Med 22 1995 346 350
69. 123I-β-CIT binding and recovery from depression A six-month follow-up study. Eur Arch Psychiatry Clin Neurosci 254 2004 152 155
70. 18F]altanserin binding to 5HT2 receptors in man Behav Brain Res 139 2003 21 29
71. 123I]β-CIT Biol Psychiatry 47 2000 371 379
72. 123I]β-CIT: pharmacological characterization of brain uptake in nonhuman primates Synapse 13 1993 295 309
73. M. Laruelle, M. Slifstein, and Y. Huang Positron emission tomography: imaging and quantification of neurotransporter availability Methods 27 2002 287 299
74. M. Laruelle, M. Slifstein, and Y. Huang Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography Mol Imaging Biol 5 2003 366 375
75. N.A. Lassen A reappraisal of the relative merits of SPET and PET in the quantitation of neuroreceptors: the advantage of a longer half-life! Eur J Nucl Med 23 1996 1 4
76. 123I]-2β-carbomethoxy-3β-(4-iodophenyl) tropane and single photon emission computed tomography Biol Psychiatry 44 1997 1090 1098
77. J.J. Mann Neurobiology of suicidal behavior Nat Rev Neurosci 4 2003 819 828
78. H.K. Manji, W.C. Drevets, and D.S. Charney The cellular neurobiology of depression Nat Med 7 2001 541 547
79. U.D. McCann, Z. Szabo, U. Scheffel, R.F. Dannals, and G.A. Ricaurte Positron emission tomographic evidence of toxic effect of MDMA ('Ecstasy') on brain serotonin neurons in human beings Lancet 352 1997 1433 1437
80. C.C. Meltzer, G. Smith, S.T. DeKosky, B.G. Pollock, C.A. Mathis, and R.Y. Moore Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging Neuropsychopharmacology 18 1997 407 430
81. J.H. Meyer, S. Kruger, A.A. Wilson, B.K. Christensen, V.S. Goulding, and A. Schaffer Lower dopamine transporter binding potential in striatum during depression Neuroreport 12 2001 4121 4125
82. J.H. Meyer, S. McMain, S.H. Kennedy, L. Korman, G.M. Brown, and J.N. DaSilva Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm Am J Psychiatry 160 2003 90 99
83. 11C]DASB positron emission tomography study Am J Psychiatry 161 2004 826 835
84. 11C]DASB PET imaging study Am J Psychiatry 158 2001 1843 1849
85. 18F]altanserin positron emission tomography Biol Psychiatry 55 2004 217 224
86. U. Müller, T. Murai, T. Bauer-Wittmund, and D.Y. von Cramon Paroxetine versus citalopram treatment of pathological crying after brain injury Brain Inj 13 1999 805 811
87. T. Murai, H. Barthel, J. Berrouschot, D. Sorger, D.Y. von Cramon, and U. Müller Neuroimaging of serotonin transporters in post-stroke pathological crying Psychiatry Res 123 2003 207 211
88. T. Murai, U. Müller, K. Werheid, D. Sorger, M. Reuter, T. Becker, and D.Y. von Cramon In vivo evidence for differential association of striatal dopamine and midbrain serotonin systems with neuropsychiatric symptoms in Parkinson's disease J Neuropsychiatry Clin Neurosci 13 2001 222 228
89. C.J. Murray, and A.D. Lopez Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study Lancet 349 1997 1497 1504
90. A. Neumeister, E. Bain, A.C. Nugent, R.E. Carson, O. Bonne, and D.A. Luckenbaugh Reduced serotonin type 1A receptor binding in panic disorder J Neurosci 24 2004 589 591
91. 123I]- 2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography Biol Psychiatry 47 2000 158 160
92. 123I-ADAM: a serotonin transporter imaging agent J Nucl Med 45 2004 834 841
93. T. Okada, M. Fujita, S. Shimada, K. Sato, P. Schloss, and Y. Watanabe Assessment of affinities of β-CIT, β-CIT-FE, and β-CIT-FP for monoamine transporters permanently expressed in cell lines Nucl Med Biol 25 1997 53 58
94. B. Olivier, W. Soudijn, and I. van Wijngaarden Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors Prog Drug Res 54 2000 59 119
95. N. Ozaki, D. Goldman, W.H. Kaye, K. Plotnicov, B.D. Greenberg, and J. Lappalainen Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype Mol Psychiatry 8 2003 933 936
96. M.C. Petit-Taboue, B. Landeau, A. Osmont, I. Tillet, L. Barre, and J.C. Baron Estimation of neocortical serotonin-2 receptor binding potential by single-dose fluorine-18-setoperone kinetic PET data analysis J Nucl Med 37 1996 95 104
97. M.L. Phillips, W.C. Drevets, S.L. Rauch, and R. Lane Neurobiology of emotion perception II: Implications for major psychiatric disorders Biol Psychiatry 54 2003 515 528
98. 123I-β- CIT SPECT: binding kinetics and effects of normal aging J Nucl Med 41 2000 36 44
99. W. Pirker, S. Asenbaum, S. Kasper, H. Walter, P. Angelberger, and G. Koch β-CIT-SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo J Neural Transm Gen Sect 100 1995 247 256
100. W.H. Poewe, and G.K. Wenning The natural history of Parkinson's disease Ann Neurol 44 1997 S1 S9
101. O. Pogarell, C. Hamann, G. Pöpperl, G. Juckel, M. Choukér, and M. Zaudig Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder Biol Psychiatry 54 2003 1406 1413
102. Y. Qu, L. Chang, J. Klaff, R. Seemann, and S.I. Rapoport Imaging brain phospholipase A2-mediated signal transduction in response to acute fluoxetine administration in unanesthetized rats Neuropsychopharmacology 28 2003 1219 1226
103. E.A. Rabiner, R.N. Gunn, M.R. Wilkins, P.A. Sargent, E. Mocaer, and E. Sedman Drug action at the 5-HT1A receptor in vivo: autoreceptor and postsynaptic receptor occupancy examined with PET and [carbonyl-11C]WAY-100665 Nucl Med Biol 27 2000 509 513
104. L. Reneman, J. Booij, K. de Bruin, J.B. Reitsma, F.A. de Wolff, and W.B. Gunning Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons Lancet 358 2001 1864 1869
105. 123I]β-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity Synapse 46 2002 199 205
106. 2A receptors in rat and human brain Neuropsychopharmacology 26 2002 387 396
107. L. Reneman, J. Lavalaye, B. Schmand, F.A. de Wolff, W. van den Brink, and G.J. den Heeten Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy'): preliminary findings Arch Gen Psychiatry 58 2001 901 906
108. 1A receptors in human brain using p-MPPF kinetic modelling and PET Eur J Nucl Med Mol Imaging 29 2002 76 81
109. 11C]WAY-100665: effects of depression and antidepressant treatment Arch Gen Psychiatry 57 2000 174 180
110. D.M. Semple, K.P. Ebmeier, M.F. Glabus, R.E. O'Carroll, and E.C. Johnstone Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users Br J Psychiatry 175 1999 66 69
111. A. Serretti, and P. Artioli From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes Psychopharmacology (Berl) 174 2004 490 503
112. K. Shioe, T. Ichimiya, T. Suhara, A. Takano, Y. Sudo, and F. Yasuno No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET Synapse 48 2003 184 188
113. 11C]McN 5652 Biol Psychiatry 54 2003 1414 1421
114. D.F. Smith Neuroimaging of serotonin uptake sites and antidepressant binding sites in the thalamus of humans and 'higher' animals Eur Neuropsychopharmacol 9 1999 537 544
115. 123I]β-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers Synapse 41 2001 275 284
116. J.K. Staley, R.T. Malison, and R.B. Innis Imaging of the serotonergic system: interactions of neuroanatomical and functional abnormalities of depression Biol Psychiatry 44 1997 534 549
117. K. Stengler-Wenzke, U. Müller, M.C. Angermeyer, O. Sabri, and S. Hesse Reduced serotonin transporter availability in obsessive-compulsive disorder (OCD) Eur Arch Psychiatry Clin Neurosci 254 2004 252 255
118. C.A. Stockmeier Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter J Psychiatr Res 37 2003 353 357
119. 11C](+)McN5652 as a radiotracer for imaging serotonin uptake sites with PET Life Sci 53 1993 883 892
120. T. Suhara, A. Takano, Y. Sudo, T. Ichimiya, M. Inoue, and F. Yasuno High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography Arch Gen Psychiatry 60 2003 386 391
121. 11C](+)McN5652 Synapse 20 1995 37 43
122. 11C]McN5652: a serotonin transporter radioligand J Cereb Blood Flow Metab 19 1999 967 981
123. L.I. Tammela, A. Rissanen, J.T. Kuikka, L.J. Karhunen, K.A. Bergström, and E. Repo-Tiihonen Treatment improves serotonin transporter binding and reduces binge eating Psychopharmacology (Berl) 170 2003 89 93
124. J. Tauscher, W. Pirker, M. de Zwaan, S. Asenbaum, T. Brücke, and S. Kasper In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment Eur Neuropsychopharmacol 9 1999 177 179
125. 123I]β-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa Biol Psychiatry 49 2001 326 332
126. R. Thomasius, K. Petersen, R. Buchert, B. Andresen, P. Zapletalova, and L. Wartberg Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users Psychopharmacology (Berl) 167 2003 85 96
127. J. Tiihonen, J.T. Kuikka, K.A. Bergström, J. Karhu, H. Viinamaki, and J. Lehtonen Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour Eur J Nucl Med 24 1997 1253 1260
128. G. Tucker Neurological disorders and depression Semin Clin Neuropsychiatry 7 2002 213 220
129. 123I]β-CIT SPECT Neurobiol Aging 21 2000 497 501
130. 123I]β-CIT SPECT in relation to serotonin transporter genotype Am J Psychiatry 161 2004 525 531
131. 18F]altanserin J Nucl Med 41 2000 234 241
132. 2a receptor binding index, hopelessness and personality characteristics in attempted suicide J Affect Disord 74 2003 149 158
133. M. Vaswani, F.K. Linda, and S. Ramesh Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review Prog Neuropsychopharmacol Biol Psychiatry 27 2003 85 102
134. 2A system: age-, gender-, and Alzheimer's disease-related findings Neurobiol Aging 24 2003 553 561
135. 11C]MDL 100,907 J Cereb Blood Flow Metab 20 2000 8111 8909
136. 123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder Biol Psychiatry 47 2000 482 489
137. M. Willeit, J. Stastny, W. Pirker, N. Praschak-Rieder, A. Neumeister, and S. Asenbaum No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism Biol Psychiatry 50 2001 8 12
138. World Health Organization. The global burden of disease. http://www.who.int/msa/mnh/ems/dalys/intro.htm
139. M. Yamamoto, T. Suhara, Y. Okubo, T. Ichimiya, Y. Sudo, and M. Inoue Age-related decline of serotonin transporters in living human brain of healthy males Life Sci 71 2002 751 757